Letter to the Editor

Hyperglycemia in an Elderly Diabetic Patient: Drug-drug or Drug-disease Interaction?

Authors: Ravi K. Bobba, MD, Edward L. Arsura, MD, FACP

Abstract

To the Editor:The use of gatifloxacin is increasing as the result of convenient dosing and efficacy in a wide range of infectious diseases. Gatifloxacin is generally well tolerated; however, recently there have been several reports of alterations in glucose levels in patients receiving gatifloxacin.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1.Khovidhunkit W, Sunthornyothin S. Hypoglycemia, hyperglycemia, and gatifloxacin. Ann Intern Med2004;141:969.
 
2.Happe MR, Mulhall BP, Maydonovitch CL, et al. Gatifloxacin induced hyperglycemia. Ann Intern Med2004;141:968–969.
 
3.Arce FC, Bhasin RS, Pasmantier R. Severe hyperglycemia during gatifloxacin therapy in patients without diabetes. Endocr Pract 2004;10:40–4.
 
4.Donaldson AR, Vandiver JR, Finch CK. Possible gatifloxacin-induced hyperglycemia. Ann Pharmacother 2004;38:602–605.
 
5.Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–245.